Outstanding Recoveries
- Home
- Outstanding Recoveries
Verdicts & Settlements
Since Milberg’s founding in 1965, the firm has recovered more than $50 billion for our clients while prompting meaningful changes in corporate governance.
Filter By
Select Practice Area
-
See More$200 Million Settlement – CMS Energy Corp. Securities Litigation
In re CMS Energy Corp. Securities Litigation, No. 02-72004 (E.D. Mich.)Milberg served as Co-Lead Counsel for the class in this securities fraud case arising out of CMS Energy’s alleged “round-trip” trading practices. The court approved a cash settlement of more than $200 million. -
See More$100 Million Settlement – General Electric Co. ERISA Litigation
In re General Electric Co. ERISA Litigation, No. 04-1398 (N.D.N.Y.)Milberg, serving as Co-Lead Counsel, achieved a $40 million settlement on behalf of current and former G.E. employees who claimed that G.E.’s 401(k) Plan fiduciaries imprudently invested more than two-thirds of the Plan’s assets in company stock. The settlement included important structural changes to G.E.’s 401(k) plan valued at more than $100 million. -
See More$580+ Million Settlement – Cathode Ray Tube (CRT) Antitrust Litigation
In re Cathode Ray Tube (CRT) Antitrust Litigation, MDL 1917 (U.S. District Court for the Northern District of California)Milberg represented indirect purchaser plaintiffs in this class action alleging an international conspiracy among defendants to keep prices for cathode ray tube (CRT) displays artificially high. Milberg had a significant discovery role in the prosecution of this class action with settlements exceeding $580 million. -
See More$54 Million Settlement – Miller v. CareCore National LLC
U.S. ex rel. Miller v. CareCore National LLC et al., No. 13-1177 (S.D.N.Y)Milberg, along with Co-Counsel, represented a whistleblower or “relator” in a false claims act case against CareCore, a company that provides benefit management services to Medicare Advantage and Medicaid Managed Care Organizations. The relator alleged that CareCore violated the False Claims Act by approving “prior authorizations” for expensive diagnostic procedures (such as MRIs) without reviewing them for medical necessity, as required. The Government intervened and the case settled in May 2017 for $54 million and the relator’s share of the settlement was $10.5 million. -
See MoreTrump Hotels Shareholder Derivative Litigation
In re Trump Hotels Shareholder Derivative Litigation, No. 96-7820 (S.D.N.Y.)The plaintiff shareholders asserted various derivative claims on behalf of the company against certain Trump entities and senior Trump executives in connection with the sale of a casino to a company in which the plaintiffs owned stock. Milberg negotiated a settlement requiring the company to increase the number of directors and the review of certain future transactions by a special committee.
